Radiomics for personalised medicine: the long road ahead
- PMID: 31937924
- PMCID: PMC7109132
- DOI: 10.1038/s41416-019-0699-8
Radiomics for personalised medicine: the long road ahead
Abstract
Radiomics is well placed to make clinically effective and cost-effective contributions to cancer care as a decision-making tool for personalised medicine. However, a systematic evaluative framework needs to be established so that these benefits can be demonstrated with confidence.
Conflict of interest statement
Family members of the author have a financial interest in Feedback PLC.
Figures
Comment on
-
MRI-based radiomics model for preoperative prediction of 5-year survival in patients with hepatocellular carcinoma.Br J Cancer. 2020 Mar;122(7):978-985. doi: 10.1038/s41416-019-0706-0. Epub 2020 Jan 15. Br J Cancer. 2020. PMID: 31937925 Free PMC article.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical